Go Deep
CONMED Corporation
CONMED Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,018 | 24.0 | 1.28 | 0.80 | 4,290.46 |
| Oct 2026 | 19,912 | 24.5 | 1.30 | 0.80 | 4,342.79 |
| Oct 2026 | 20,292 | 24.6 | 1.31 | 0.80 | 4,337.90 |
| Oct 2026 | 20,359 | 24.3 | 1.29 | 0.80 | 4,265.99 |
| Oct 2026 | 20,120 | 25.5 | 1.36 | 0.80 | 4,476.46 |
| Oct 2026 | 20,165 | 25.7 | 1.34 | 0.80 | 4,425.08 |
| Oct 2026 | 20,238 | 25.3 | 1.32 | 0.80 | 4,366.29 |
| Oct 2026 | 20,073 | 25.7 | 1.37 | 0.80 | 4,511.36 |
| Oct 2026 | 20,124 | 25.5 | 1.35 | 0.80 | 4,455.77 |
| Oct 2026 | 19,872 | 26.7 | 1.42 | 0.80 | 4,666.68 |
CONMED Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 343,488,000.0 | 317,046,000.0 | 373,198,000.0 | 337,926,000.0 |
| Net Profit | 23,071,000.0 | 13,828,000.0 | 16,739,000.0 | 2,859,000.0 |
| EPS | 0.8 | 0.5 | 0.5 | 0.1 |
CONMED Corporation Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 1,374,724,000.0 | 1,307,015,000.0 | 1,244,744,000.0 | 1,045,472,000.0 | — |
| Net Profit | 47,055,000.0 | 132,423,000.0 | 64,459,000.0 | -80,582,000.0 | — |
| EPS | 1.5 | 4.3 | 2.1 | -2.7 | — |
CONMED Corporation Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 2,325,749,000.0 | 2,306,247,000.0 | 2,300,021,000.0 | 2,297,592,000.0 | — |
| Total Liabilities | 1,292,652,000.0 | 1,343,566,000.0 | 1,465,799,000.0 | 1,552,047,000.0 | — |
| Total Equity | 1,033,097,000.0 | 962,681,000.0 | 834,222,000.0 | 745,545,000.0 | — |
Owes vs Owns
CONMED Corporation owed $0.55 for every $1 it owned in Jun 2026, down from $0.68 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.55× | 0.56× | 0.58× | 0.64× | 0.68× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
CONMED Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 1.8%Receivables 10.7%Inventory 15.3%Fixed assets (tangible) 4.9%Intangible assets 59.7%Other assets 7.7%
How it's funded — Dec 2025
Long-term debt 35.9%Payables 4.0%Other liabilities 15.7%Shareholders' equity 44.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 40.8 | 24.5 | 24.3 | 28.9 |
| Receivables | 247.8 | 237.7 | 242.3 | 191.3 |
| Inventory | 355.5 | 346.7 | 318.3 | 332.3 |
| Fixed assets (tangible) | 113.3 | 115.8 | 120.7 | 115.6 |
| Intangible assets | 1,389.1 | 1,423.0 | 1,456.3 | 1,497.2 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 179.2 | 158.5 | 138.1 | 132.1 |
| Liabilities & equity | ||||
| Short-term debt | 0.7 | 0.7 | 0.7 | 69.7 |
| Long-term debt | 834.2 | 905.1 | 973.1 | 985.1 |
| Payables | 93.6 | 102.2 | 88.2 | 73.4 |
| Other liabilities | 364.1 | 335.5 | 403.7 | 423.8 |
| Shareholders' equity | 1,033.1 | 962.7 | 834.2 | 745.5 |
| Net tangible assets | -356.0 | -460.3 | -622.1 | -751.7 |
CONMED Corporation Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 170,689,000.0 | 166,968,000.0 | 125,348,000.0 | 33,365,000.0 | — |
| Investing Activities | -20,956,000.0 | -13,084,000.0 | -20,032,000.0 | -249,529,000.0 | — |
| Financing Activities | -135,820,000.0 | -151,000,000.0 | -110,432,000.0 | 225,000,000.0 | — |